Home / Drug shortages / Sodium Bicarbonate Injection

Sodium Bicarbonate Injection — FDA Drug Shortage

To Be Discontinued — Hospira, Inc., a Pfizer Company

The FDA lists a drug shortage record for Sodium Bicarbonate Injection (injection) from Hospira, Inc., a Pfizer Company with status To Be Discontinued. The shortage was first posted on 11/07/2025.

Shortage Details

Status
To Be Discontinued
Company
Hospira, Inc., a Pfizer Company
Package NDC
0409-5534-14
Dosage Form
Injection
Presentation
Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 0409-5534-14)
Initial Posting
11/07/2025
Revised Date

FDA data resources